Latest From Biotech Now

Correcting the Record On Politico’s Misinformed Article


Politico recently explored the relationship between the biopharmaceutical industry and the Affordable Care Act (ACA). The article laments the supposed high cost of drugs and implicitly endorses policies that would not only do little for patients in need of medications, but also stifle innovation through research and development. The implication that the “structural reforms” the story talks about would fundamentally change drug costs in this country is myopic and misinformed. Those so-called “reforms” like top-down, Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , ,

A Rehash Of Tired, Old Ideas From President Obama


Many of the biopharmaceutical policy proposals laid out by President Obama in his JAMA article (United States Health Care Reform: Progress to Date and Next Steps) are simply a rehash of tired, old ideas that have been rejected by bipartisan majorities in the Congress for years. The plans he lays out would do little or nothing to improve our shared goal of increasing patients’ access to medicines and could impede the development of new medical Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , ,

BIO Applauds Federal Approach to GMO Disclosure


BIO applauds today’s vote in the U.S. House of Representatives to approve a federal, uniform approach to GMO disclosure.  The House voted 306-117 shortly after noon today, sending the long-debated bill to President Obama’s desk for signature. “The Congress’ strong, bipartisan support for a national GMO labeling and disclosure solution is a win for consumers, farmers, businesses, and agricultural innovation,” said Jim Greenwood, BIO’s President and CEO. “We commend the many leaders in the U.S. Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Innovation and Choice: Leading Today’s GMO Conversations

CBI table for twenty bardzik

To commemorate 20 years of biotech innovation, we invited a diverse group of experts in academia, agriculture, science and media to discuss “The Future of GMOs & Their Role in Sustainability.” During the discussion, experts explored the impact of biotechnology and what’s next in the future. Through lively discussion and debate, several key points came to light. Naomi Stevens, global head of Market Acceptance for Seeds at Bayer, notes that the farmers who produce our food Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

BIO Adds Nikon Instruments Inc. to Membership Discount Program


BIO Business Solutions®, BIO’s cost-savings program, has announced a new partnership with Nikon Instruments Inc. The Nikon Instruments Research Grade Microscope Systems Program is available to members of BIO and select endorsing affiliate offers a wide selection of research instrumentation and digital imaging solutions for microscopy for direct purchase. Member benefits include select discounts on microscope packages, individual items, free installation, 1 Year Warranty on Systems, 5 Year Warranty on Microscopes, 15% off Warranty Extension Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , ,